Clinical Trial Registries Pose Benefits, Risks, GSK Executive Says

Drug Industry Daily
KEYWORDS FDA / Trial
A A

Drugmakers can reduce their liability risks and avoid other pitfalls associated with establishing clinical trial databases by using a review team to ensure trial results are complete and free of promotional claims, says a GlaxoSmithKline (GSK) executive.

To View This Article:

Login

Subscribe To Drug Industry Daily